Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the first minimally-invasive heart procedure using its new real-time 3D ...
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the introduction of its VeriSight Pro 3D Intracardiac Echocardiography (ICE) ...
Global introduction 1 of innovative imaging tool designed to support the treatment of cardiovascular diseases, including structural heart disease repairs, without the need for open heart surgery World ...
On May 19, Koninklijke Philips N.V. (NYSE:PHG) introduced VeriSight Pro 3D Intracardiac Echocardiography (ICE) catheter in Europe, enhancing real-time heart imaging without general anesthesia.
EchoNavigator 4.0 empowers heart teams with greater control of live fusion imaging plus new anatomical modeling and transseptal puncture guidance during minimally-invasive procedures Seamless ...
Health technology company Royal Philips announced the release of Transcend Plus, its EPIQ CVx and Affiniti CVx cardiovascular ultrasound systems. Transcend Plus features FDA-cleared 2D- and 3D-image ...
Philips announces first patient treated with its new real-time 3D intracardiac echocardiography catheter – VeriSight Pro GlobeNewswire July 01, 2021 FDA 510k-cleared real-time 3D intracardiac ...
FDA 510k-cleared real-time 3D intracardiac echocardiography (ICE) catheter has potential to improve standard of care for structural heart disease and electrophysiology procedures Reduced need for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback